New York, NY - Ipsos is pleased to be one of the founding sponsors of the Principles of Pharmaceutical Marketing Research course offered by the University of Georgia Center for Continuing Education. Its twelve comprehensive modules cover the fundamentals needed for market research professionals to proficiently tackle industry challenges.
Principles of Pharmaceutical Marketing Research is touted as being the profession’s highest quality, most valued, and most widely supported educational program. Individuals representing dozens of industries in more than 60 countries have taken the course.
As a global leader in pharmaceutical market research, Ipsos found the course matches well to its expertise. The material encompasses everything from survey design to final results communication, for both qualitative and quantitative methodologies.
Elys Roberts, President and CEO for Ipsos Marketing, Healthcare Practice, and board member of the MRII, saw this sponsorship as an opportunity to support a high-quality, valuable program that provides educational tools to help both new and seasoned market research professionals excel.
“We are extremely proud to be a sponsor for such a strong course,” said Roberts. “We are pleased to be able to show our commitment to supporting learning and best practice in the industry. At Ipsos, we strive to be as innovative as possible, to provide the best solutions and insight for our clients. Having a firm grasp of core competencies undoubtedly strengthens the ability for researchers to have the confidence to be creative. It is our pleasure to help support it.”
Principles of Pharmaceutical Marketing Research is provided by The Marketing Research Institute International (MRII), a non profit dedicated to fulfilling the core educational needs of research professionals worldwide, in partnership with the University of Georgia Center for Continuing Education. It is the first self-paced, self-study, online certificate designed for this specific audience.
For more information about the course: www.georgiacenter.uga.edu/is/mrpharma/index.phtml.
For more information on this news release, please contact:
About Ipsos Marketing
Senior Vice President
Ipsos Health Marketing
Ipsos Marketing is a global survey-based marketing research consultancy that helps clients to innovate to drive business growth.
From the earliest stages of innovation through brand maturity, our experienced research teams provide world-class solutions to help clients build their businesses. We offer advanced research tools for consumer and market understanding, idea generation, concept development, mix development and optimization, forecasting and modeling, and brand management and repositioning. We pride ourselves on excellence in client service and thought leadership.
Ipsos Marketing partners with clients in a broad range of sectors including consumer goods, retail, durables, health, technology, financial services, automotive, tourism, transportation, agrifood, utilities, and more.
Ipsos Marketing is a specialization of Ipsos, a leading global survey-based market research company that offers expertise in advertising, customer and employee loyalty, marketing, media, and public affairs research, as well as forecasting, modeling, and consulting.
To learn more, please visit www.ipsosmarketing.com.
Ipsos is a leading global survey-based market research company, owned and managed by research professionals. Ipsos helps interpret, simulate, and anticipate the needs and responses of consumers, customers, and citizens around the world.
Member companies assess market potential and interpret market trends. They develop and build brands. They help clients build long-term relationships with their customers. They test advertising and study audience responses to various media. They measure public opinion around the globe.
Ipsos member companies offer expertise in advertising, customer loyalty, marketing, media, and public affairs research, as well as forecasting, modeling, and consulting. Ipsos has a full line of custom, syndicated, omnibus, panel, and online research products and services, guided by industry experts and bolstered by advanced analytics and methodologies. The company was founded in 1975 and has been publicly traded since 1999.
In 2007, Ipsos generated global revenues of €927.2 million ($1.27 billion U.S.).
Visit www.ipsos.com to learn more about Ipsos offerings and capabilities.
Ipsos, listed on the Eurolist of Euronext – Comp B, is part of SBF 120 and the Mid-100 Index, adheres to the Next Prime segment and is eligible to the Deferred Settlement System. Isin FR0000073298, Reuters ISOS.PA, Bloomberg IPS:FP